Prenylated flavonoids possess a wide
variety of biological activities,
including estrogenic, antioxidant, antimicrobial, and anticancer activities.
Hence, they have potential applications in food products, medicines,
or supplements with health-promoting activities. However, the low
abundance of prenylated flavonoids in nature is limiting their exploitation.
Therefore, we investigated the prospect of producing prenylated flavonoids
in the yeast Saccharomyces cerevisiae. As a proof of concept, we focused on the production of the potent
phytoestrogen 8-prenylnaringenin. Introduction of the flavonoid prenyltransferase
SfFPT from Sophora flavescens in naringenin-producing
yeast strains resulted in de novo production of 8-prenylnaringenin.
We generated several strains with increased production of the intermediate
precursor naringenin, which finally resulted in a production of 0.12
mg L–1 (0.35 μM) 8-prenylnaringenin under
shake flask conditions. A number of bottlenecks in prenylated flavonoid
production were identified and are discussed.